UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

Proceedings of the National Academy of Sciences - PNAS, 1999-09, Vol.96 (19), p.10824-10829

1999

Volltextzugriff (PDF)

Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure

Molecular pharmacology, 1994-02, Vol.45 (2), p.182-188

1994

Volltextzugriff (PDF)

In Vitro Antioxidant Neuroprotective Activity of BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2079-2086

2000

Volltextzugriff (PDF)

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Volltextzugriff (PDF)

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Blood, 2010-10, Vol.116 (14), p.2448-2454

2010

Volltextzugriff (PDF)

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6C high Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70-A71

2013

Volltextzugriff (PDF)

A9.17Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70-A71

2013

Volltextzugriff (PDF)

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70

2013

Volltextzugriff (PDF)

A4.4MIR-146A deficiency in LY6Chigh monocytes contributes to pathogenic bone loss during inflammatory arthritis

Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A37-A38

2015

Volltextzugriff (PDF)

A4.4 MIR-146A deficiency in LY6C high monocytes contributes to pathogenic bone loss during inflammatory arthritis

Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A37-A38

2015

Volltextzugriff (PDF)

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

European journal of haematology, 2011-10, Vol.87 (4), p.338-348

2011

Volltextzugriff (PDF)

CKD ANAEMIA

Nephrology, dialysis, transplantation, 2014-05, Vol.29 (suppl 3), p.iii21-iii22

2014

Volltextzugriff (PDF)

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with -thalassemia major

Haematologica (Roma), 2012-06, Vol.97 (6), p.842-848

2012

Volltextzugriff (PDF)

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

Haematologica (Roma), 2011-01, Vol.96 (1), p.48-54

2011

Volltextzugriff (PDF)

Vascular mechanism of action of endothelin-1: Effect of Ca super(2+) antagonists

Journal of cardiovascular pharmacology, 1989-01, Vol.13, p.no. Sul. 5-no. Sul. 5

1989

Volltextzugriff (PDF)

Effects and specific binding sites of endothelin in human lung preparations

Pulmonary pharmacology (Edinburgh), 1991, Vol.4 (1), p.54-59

1991

Volltextzugriff (PDF)

Multiplicity of endothelin receptors of aortic smooth muscle cells in rats

Archives des maladies du coeur et des vaisseaux, 1991-08, Vol.84 (8), p.1057

1991

Volltextzugriff (PDF)

Homologous and heterologous regulations of endothelin receptors on smooth muscle cells

Archives des maladies du coeur et des vaisseaux, 1990-07, Vol.83 (8), p.1183

1990

Volltextzugriff (PDF)

Endothelin receptors and endothelin-1 immunoreactivity in the human lung

Archives des maladies du coeur et des vaisseaux, 1991-08, Vol.84 (8), p.1065

1991

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(19)

Sprache

Englisch
(16)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure

In Vitro Antioxidant Neuroprotective Activity of BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6C high Monocyte Subset for Therapeutic Intervention in Arthritis

A9.17Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

A4.4MIR-146A deficiency in LY6Chigh monocytes contributes to pathogenic bone loss during inflammatory arthritis

A4.4 MIR-146A deficiency in LY6C high monocytes contributes to pathogenic bone loss during inflammatory arthritis

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

CKD ANAEMIA

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with -thalassemia major

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

Vascular mechanism of action of endothelin-1: Effect of Ca super(2+) antagonists

Effects and specific binding sites of endothelin in human lung preparations

Multiplicity of endothelin receptors of aortic smooth muscle cells in rats

Homologous and heterologous regulations of endothelin receptors on smooth muscle cells

Endothelin receptors and endothelin-1 immunoreactivity in the human lung

Aktive Filter

Suchergebnisse filtern